Free Trial

Wellington Management Group LLP Takes Position in Afya Limited (NASDAQ:AFYA)

Afya logo with Consumer Discretionary background

Wellington Management Group LLP purchased a new stake in shares of Afya Limited (NASDAQ:AFYA - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor purchased 52,203 shares of the company's stock, valued at approximately $829,000. Wellington Management Group LLP owned about 0.06% of Afya at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in AFYA. Blue Trust Inc. boosted its position in shares of Afya by 296.9% during the fourth quarter. Blue Trust Inc. now owns 2,072 shares of the company's stock valued at $35,000 after buying an additional 1,550 shares during the period. Public Employees Retirement System of Ohio increased its stake in Afya by 40.0% in the fourth quarter. Public Employees Retirement System of Ohio now owns 2,800 shares of the company's stock worth $44,000 after purchasing an additional 800 shares during the period. Tower Research Capital LLC TRC lifted its position in shares of Afya by 1,099.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 4,031 shares of the company's stock worth $64,000 after purchasing an additional 3,695 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Afya by 2,115.9% during the fourth quarter. JPMorgan Chase & Co. now owns 6,670 shares of the company's stock valued at $106,000 after purchasing an additional 6,369 shares during the period. Finally, Aquatic Capital Management LLC increased its stake in Afya by 47.6% in the 4th quarter. Aquatic Capital Management LLC now owns 9,300 shares of the company's stock worth $148,000 after buying an additional 3,000 shares during the period. 88.02% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently commented on AFYA. Wall Street Zen lowered shares of Afya from a "buy" rating to a "hold" rating in a research report on Friday. Morgan Stanley cut Afya from an "equal weight" rating to an "underweight" rating and lowered their target price for the stock from $19.00 to $17.00 in a report on Tuesday, March 11th. Three equities research analysts have rated the stock with a sell rating and three have issued a hold rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $17.60.

Read Our Latest Stock Analysis on Afya

Afya Stock Up 1.2%

Afya stock traded up $0.21 during mid-day trading on Tuesday, reaching $17.76. 270,778 shares of the company were exchanged, compared to its average volume of 125,367. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.60 and a current ratio of 1.60. The firm has a market cap of $1.66 billion, a P/E ratio of 14.32, a PEG ratio of 0.29 and a beta of 0.60. The business has a fifty day moving average of $18.37 and a 200 day moving average of $17.14. Afya Limited has a 12-month low of $14.52 and a 12-month high of $19.90.

Afya Announces Dividend

The company also recently announced a -- dividend, which was paid on Friday, April 4th. Shareholders of record on Wednesday, March 26th were issued a $0.232 dividend. The ex-dividend date of this dividend was Wednesday, March 26th. Afya's dividend payout ratio is presently 17.42%.

Afya Profile

(Free Report)

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

Recommended Stories

Institutional Ownership by Quarter for Afya (NASDAQ:AFYA)

Should You Invest $1,000 in Afya Right Now?

Before you consider Afya, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.

While Afya currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?
These 3 Penny Stocks Could Surprise Everyone This Summer!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines